PlainRecalls
FDA Devices Moderate Class II Ongoing

VIDAS Lyme IgG II (LYM), REF 417401

Reported: January 5, 2022 Initiated: September 22, 2021 #Z-0437-2022

Product Description

VIDAS Lyme IgG II (LYM), REF 417401

Reason for Recall

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

Details

Recalling Firm
bioMerieux, Inc.
Units Affected
Two lots
Distribution
US Nationwide distribution.
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
VIDAS Lyme IgG II (LYM), REF 417401. Recalled by bioMerieux, Inc.. Units affected: Two lots.
Why was this product recalled?
bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 5, 2022. Severity: Moderate. Recall number: Z-0437-2022.